Traders should monitor for upcoming financing announcements or delays in R&D progress; absence of near-term capital raises could signal heightened bankruptcy risk given operational downsizing.
Price Chart
Executive Summary
Lunai Bioworks Inc. (LNAI) implemented a temporary furlough of its U.S. and Canada employees on February 27, 2026, to preserve liquidity amid ongoing efforts to secure additional financing. The CEO and CFO have voluntarily deferred their salaries, and only limited operations are being maintained.
Key Facts
- Company implemented a temporary furlough of employees in the U.S. and Canada on February 27, 2026
- Furlough is intended to preserve liquidity while pursuing additional financing
- CEO and CFO have voluntarily deferred their salaries
- Only limited operations are ongoing; some employees are being recalled to support platform development
- Duration of furlough depends on the company's ability to secure capital
Financial Impact
Significant cost reduction expected from employee furlough and executive salary deferral, but no specific dollar figures disclosed
Risk Factors
- Failure to secure additional financing could lead to prolonged furlough, permanent layoffs, or insolvency
- Operational delays may impact platform development timelines and future revenue potential
- Investor confidence may decline due to signs of financial distress
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001731122-26-000345 |
| Document: 0001731122-26-000345-index-headers.html | 0001731122-26-000345 |
| Document: 0001731122-26-000345-index.html | 0001731122-26-000345 |
| Document: 0001731122-26-000345.txt | 0001731122-26-000345 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $0.2946 $0.2750 | ▲ +6.65% | ▲ +7.36% | $0.2750 (+6.65%) |
Oct 15, 2026 10d ago | SC 13D/A | $0.6800 $0.4720 | ▲ +30.59% | ▲ +31.01% | $0.2750 (+59.56%) |
Oct 9, 2026 17d ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +9.70% | $0.2750 (+77.64%) |
Sep 29, 2026 27d ago | NT 10-K | $1.47 $1.38 | ▲ +6.12% | ▲ +6.30% | $0.2750 (+81.29%) |
Jun 17, 2026 18w ago | 8-K | $3.78 $4.15 | ▲ +9.79% | ▲ +10.10% | $0.2750 (−92.72%) |
Jun 16, 2026 18w ago | 8-K | $4.00 $3.78 | ▼ −5.50% | ▼ −6.28% | $0.2750 (−93.12%) |
May 20, 2026 22w ago | 8-K | $1.80 $2.32 | ▼ −28.89% | ▼ −28.69% | $0.2750 (+84.72%) |
May 1, 2026 25w ago | 8-K | $2.60 $2.50 | ▼ −3.88% | ▼ −4.68% | $0.2750 (−89.41%) |
Apr 28, 2026 25w ago | DEFA14A | $2.66 $2.64 | ▼ −0.90% | ▼ −1.92% | $0.2750 (−89.68%) |
Mar 5, 2026 33w ago | 8-K | $1.86 $1.76 | ▲ +5.25% | ▲ +6.10% | $0.2750 (+85.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers